A new study highlighted the need to monitor long-term variability in blood pressure and mean blood pressure alongside ...

Ripple will lead preclinical development of RTC-620 while AbbVie will lead the clinical and commercialization activities upon exercise of option-to-license agreement.

Glaucoma is a group of eye diseases that cause slow, progressive damage to the optic nerve in the back of the eye, says Schultz. This growing damage is due to unsafe fluid buildup that causes ...

Childhood myopia has emerged as a global public health concern, with its prevalence rapidly increasing worldwide. Myopia is typically diagnosed in early childhood and often progresses throughout ...

There have been numerous recent advances in the management of glaucoma, not least the development of new drugs to help manage raised intraocular pressure. In addition, the concepts of improving ...

Frailty and glaucoma may have a proportional relationship, and patients with higher frailty metrics may face significant barriers to regular eye screening and disease management.

University of California, San Diego-led research suggests that long-term variability in blood pressure is associated with accelerated worsening of peripheral vision due to the progression of glaucoma.

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Researchers have found that higher mean blood pressure (BP) values and increased BP variability are correlated with higher ...

This significant reduction in dosing frequency underscores the potential for LL-BMT1 to improve patient compliance and outcomes in glaucoma management. Enhanced Comfort and Eye Health with Sustained ...

Glaucoma encompasses a heterogeneous group of eye diseases associated with progressive loss of optic nerve fibers, with ...